Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

Folks undergoing cardiac catheterization procedures to diagnose heart problems may be able to safely skip the traditional pre-op fasting that's now the norm, new research shows. "Just as our ...

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...

Long Beach, Calif. – May 2, 2024 – New data from the CALORI Cardiac Catheterization trial shows significant improvement in patient well-being and satisfaction without compromising safety after ...

Intermittent catheterisation (IC) remains a pivotal intervention in managing neurogenic bladder dysfunction among spinal cord injury patients. By facilitating periodic bladder emptying, IC helps to ...

The days of prolonged fasting prior to cardiac catheterization may be numbered, as the body of evidence grows to allow patients to eat before the procedure. Patients undergoing coronary artery ...

Patient volume is one of the biggest challenges for catheterization labs, with 44.8 percent of lab leaders and staff citing it as the number one challenge in 2011 and 41.4 percent saying it will ...

Chest pain can be serious and should never be ignored, especially if the sensation is new or unexplained. This can be a warning sign of cardiac function complications. Reduced blood flow to the heart ...

HOUSTON, TN — The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement for managing patients with cancer who are seen in the cardiac ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...